Search Results - "Hakimi, Jalil"

  • Showing 1 - 10 results of 10
Refine Results
  1. 1
  2. 2

    An adjuvant-modulated vaccine response in human whole blood by Hakimi, Jalil, Azizi, Ali, Ausar, Salvador F., Todryk, Stephen M., Rahman, Nausheen, Brookes, Roger H.

    Published in Human vaccines & immunotherapeutics (02-09-2017)
    “…The restimulation of an immune memory response by in vitro culture of blood cells with a specific antigen has been used as a way to gauge immunity to vaccines…”
    Get full text
    Journal Article
  3. 3

    Significance of the CAG repeat polymorphism of the androgen receptor gene in prostate cancer progression by Nam, R K, Elhaji, Y, Krahn, M D, Hakimi, J, Ho, M, Chu, W, Sweet, J, Trachtenberg, J, Jewett, M A, Narod, S A

    Published in The Journal of urology (01-08-2000)
    “…The CAG repeat polymorphism of the androgen receptor gene has been associated with an increased prostate cancer risk, and the repeat length correlated with…”
    Get more information
    Journal Article
  4. 4

    Screening Vaccine Formulations in Fresh Human Whole Blood by Hakimi, Jalil, Aboutorabian, Sepideh, To, Frederick, Ausar, Salvador F, Rahman, Nausheen, Brookes, Roger H

    “…Monitoring the immunological functionality of vaccine formulations is critical for vaccine development. While the traditional approach using established animal…”
    Get more information
    Journal Article
  5. 5

    A high ratio of IC31® adjuvant to antigen is necessary for H4 TB vaccine immunomodulation by Aboutorabian, Sepideh, Hakimi, Jalil, Boudet, Florence, Montano, Sandrine, Dookie, Annie, Roque, Cristopher, Ausar, Salvador F, Rahman, Nausheen, Brookes, Roger H

    Published in Human vaccines & immunotherapeutics (03-06-2015)
    “…A tuberculosis (TB) vaccine consisting of a recombinant fusion protein (H4) and a novel TLR9 adjuvant (IC31) is in clinical development. To better understand…”
    Get full text
    Journal Article
  6. 6

    A sensitive flow cytometry-based cytotoxic T-lymphocyte assay through detection of cleaved caspase 3 in target cells by He, Liwei, Hakimi, Jalil, Salha, Danielle, Miron, Ioana, Dunn, Pamela, Radvanyi, Laszlo

    Published in Journal of immunological methods (01-09-2005)
    “…We describe a highly sensitive flow cytometry-based CTL assay using the cleavage of caspase 3 in target cells as a readout. The assay involved labeling of…”
    Get full text
    Journal Article
  7. 7

    Screening vaccine formulations for biological activity using fresh human whole blood by Brookes, Roger H, Hakimi, Jalil, Ha, Yukyung, Aboutorabian, Sepideh, Ausar, Salvador F, Hasija, Manvi, Smith, Steven G, Todryk, Stephen M, Dockrell, Hazel M, Rahman, Nausheen

    Published in Human vaccines & immunotherapeutics (28-04-2014)
    “…Understanding the relevant biological activity of any pharmaceutical formulation destined for human use is crucial. For vaccine-based formulations, activity…”
    Get full text
    Journal Article
  8. 8

    Is Uterine Papillary Serous Adenocarcinoma a Manifestation of the Hereditary Breast–Ovarian Cancer Syndrome? by Goshen, Ran, Chu, William, Elit, Laurie, Pal, Tuya, Hakimi, Jalil, Ackerman, Ida, Fyles, Anthony, Mitchell, Margot, Narod, Steven A.

    Published in Gynecologic oncology (01-12-2000)
    “…Background. Uterine papillary serous carcinoma (UPSC) shares common pathologic, genetic, and clinical features with other serous cancers of müllerian origin…”
    Get full text
    Journal Article
  9. 9

    A rapid fluorescent multiplexed-PCR analysis (FMPA) for founder mutations in the BRCA1 and BRCA2 genes by Kuperstein, Graciela, Foulkes, William D, Ghadirian, Parviz, Hakimi, Jalil, Narod, Steven A

    Published in Clinical genetics (01-03-2000)
    “…Mutations of the BRCA1 and BRCA2 genes account for approximately 80% of hereditary breast/ovarian cancer families, but the size of these two genes makes…”
    Get full text
    Journal Article
  10. 10

    A rapid fluorescent multiplexed‐PCR analysis (FMPA) for founder mutations in the BRCA 1 and BRCA 2 genes by Kuperstein, Graciela, Foulkes, William D, Ghadirian, Parviz, Hakimi, Jalil, Narod, Steven A

    Published in Clinical genetics (01-03-2000)
    “…Mutations of the BRCA 1 and BRCA 2 genes account for approximately 80% of hereditary breast/ovarian cancer families, but the size of these two genes makes…”
    Get full text
    Journal Article